Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation. 00:00 intro 01:01 pathology and AI 13:30 nailing go-to-market strategy 19:47 how pathology labs can go digital 25:36 regulatory frameworks and roadblocks 33:05 do improvements in foundation models impact PathAI? 36:26 standardizing diagnosis 40:05 how will the job of a pathologist change going forward? 42:35 NASH 47:30 working in Daphne Koller’s lab With your co-hosts: @jasoncwarner - Former CTO GitHub, VP Eng Heroku & Canonical @ericabrescia - Former COO Github, Founder Bitnami (acq’d by VMWare) @patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn @jacobeffron - Partner at Redpoint, Former PM Flatiron Health @jordan_segall - Partner at Redpoint

0 Comments Sort By